11:54 AM EST, 12/04/2024 (MT Newswires) -- Scienture ( SCNX ) filed a registration statement with the US Securities and Exchange Commission Wednesday for the potential sale of up to 4.3 million common shares by certain shareholders.
The pharmaceutical company said it will not receive any proceeds from the secondary stock offering.
Price: 7.41, Change: +0.01, Percent Change: +0.14